Table 5

Prevalence of CVD risk enhancing factors not included in risk scores in WHO/ISH charts by risk category
Cambodia (N = 3090) Malaysia (N = 1618) Mongolia (N = 764)
Low (n = 3003) Mod (n = 48) High (n = 38) Total Low (n = 1484) Mod (n = 60) High (n = 60) Total Low (n = 674) Mod (n = 36) High (n = 54) Total
Obesity 2.3 (1.8-3.0) 11.8 (4.7-26.2) 0.9 (0.1-6.8) 2.4 (1.9-3.1) 15.3 (12.3-8.8) 18.9 (14.6-4.2) 34.0 (28.2-0.4) 15.8 (13.0-9.1) 23.9 (19.7-8.7) 37.1 (21.8-55.3) 42.0 (27.3-58.3) 25.7 (21.6-30.3)
Low physical activity 9.7 (8.4-11.2) 12.6 (5.5-26.3) 6.1 (1.5-21.3) 9.7 (8.4-11.2) 27.4 (23.9-1.2) 28.3 (18.3-1.2) 14.3 (5.1-34.0) 27.2 (23.7-1.0) 8.3 (5.4-12.7) 9.9 (2.5-32.2) 16.3 (6.4-35.8) 8.9 (5.8-13.5)
High pulse rate 15.3 (13.9-16.9) 16.6 (8.4-30.0) 30.1 (16.0-49.2) 15.5 (14.1-17.1) 6.6 (4.9-8.7) 12.7 (7.9-19.7) 18.5 (10.0-31.6) 7.1 (5.4-9.1) 14.1 (11.0-7.8) 6.0 (1.4-21.9) 20.4 (11.2-34.2) 14.1 (11.3-17.5)
Currently on HT medication 6.2 (5.2-7.5) 15.3 (7.5-28.7) 43.7 (28.3-60.4) 6.9 (5.8-8.2) 12.3 (3.6-34.8) 37.7 (20.8-58.3) 31.9 (19.8-47.0) 13.6 (4.3-35.4) 18.8 (14.6-3.8) 52.1 (33.2-70.5) 68.7 (50.3-82.6) 23.6 (18.9-29.1)
High triglycerides na na na na 27.5 (22.0-33.4) 52.0 (45.3-58.5) 40.9 (34.0-48.3) 28.5 (23.5-34.1) 18.8 (13.3-5.9) 23.1 (10.6-43.1) 7.0 (2.7-17.2) 18.2 (13.2-24.6)
Low HDL na na na na 27.3 (24.0-30.9) 25.8 (14.1-42.3) 36.2 (29.0-44.1) 27.4 (24.1-31.1) 20.7 (14.9-7.9) 38.0 (21.0-58.6) 32.1 (19.1-48.4) 22.2 (16.2-29.8)

Otgontuya et al.

Otgontuya et al. BMC Public Health 2013 13:539   doi:10.1186/1471-2458-13-539

Open Data